Abstract:p53 (TP53) is the most frequently mutated gene in squamous cell carcinomas (SCCs) of the skin and head and neck. Certain p53 mutations are oncogenic and promote invasion and metastasis in SCCs. However, it is unclear how the oncogenic function of mutant p53 is modulated by other molecular alterations that co-exist in SCCs. Here, we show that deletion of the p53 gene and activation of an endogenous This article is protected by copyright. All rights reserved. This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/path.4770 A cc ep te d A rti cl e p53 gain-of-function mutation in the skin induces carcinomas with similar kinetics and penetrance. Deletion of p53 induced primarily well-differentiated SCCs. However, most of the tumours induced by p53 were poorly differentiated SCCs, the only metastatic tumours in this model. These tumours expressed higher levels of Cyclin D1 than the well differentiated SCCs and spindle carcinomas that developed in these mice. Unexpectedly, metastasis was not observed in mice that developed spindle carcinomas, which expressed high levels of the tumour suppressors p16 and p19, encoded by Cdkn2a, a gene frequently deleted in human SCCs. Remarkably, deletion of the Cdkn2a gene in p53-induced SCCs promoted a dramatic increase in metastasis rates and a shorter survival in mice that developed these tumours, compared with those observed in mice with tumours in which Cdkn2a was deleted in the presence of a p53 loss-of-function mutation or wild-type p53. Accordingly, the survival of patients with head and neck SCCs bearing co-occurring high-risk p53 mutations and CDKN2A homozygous deletions was much shorter than that of patients with tumours in which high-risk p53 mutations did not contain CDKN2A homozygous deletions, or that of patients with tumours in which homozygous CDKN2A deletions co-existed with either low-risk p53 mutations or potential loss-of-function mutations in p53. These findings genetically identify a population of SCC patients with worst outcomes and will help predict outcomes according to the p53 status and alterations in CDKN2A.

Pten Loss in Lgr5+ Hair Follicle Stem Cells Promotes SCC Development

Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma

Loss of TGF-β Signaling and PTEN Promotes Head and Neck Squamous Cell Carcinoma Through Cellular Senescence Evasion and Cancer-Related Inflammation

Abstract 4324: Loss of TGF-beta Receptor I and PTEN Promotes HNSCC

Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice.

Impaired Notch Signaling Promotes De Novo Squamous Cell Carcinoma Formation

Loss of Pten Causes Tumor Initiation Following Differentiation of Murine Pluripotent Stem Cells Due to Failed Repression of Nanog.

Data from Lin<sup>−</sup>Sca-1<sup>+</sup>CD49f<sup>high</sup> Stem/Progenitors Are Tumor-Initiating Cells in the <i>Pten</i>-Null Prostate Cancer Model

LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice

Role of PTEN in basal cell derived lung carcinogenesis.

Lgr4 is Crucial for Skin Carcinogenesis by Regulating MEK/ERK and Wnt/β-catenin Signaling Pathways

Pten deletion leads to the expansion of a prostatic stemprogenitor cell subpopulation and tumor initiation

Pten Loss Promotes Ras(Ha)-Mediated Papillomatogenesis Via Dual Up-Regulation of Akt Activity and Cell Cycle Deregulation but Malignant Conversion Proceeds Via Pten-Associated Pathways

Epithelial stem cell mutations that promote Squamous cell carcinoma metastasis

Loss of Cathepsin C Enhances Keratinocyte Proliferation and Inhibits Apoptosis

Multi-genetic Events Collaboratively Contribute to Pten -Null Leukaemia Stem-Cell Formation

Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis.

Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.

Mutations in Long-Lived Epithelial Stem Cells and Their Clonal Progeny in Pre-Malignant Lesions and in Oral Squamous Cell Carcinoma.

LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways

Mutant p 53 and Cdkn 2 a deletion induce metastatic SCCs